- Home
- OSCR vs IMVT Comparison
OSCR vs IMVT Comparison
Compare OSCR & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSCR
- IMVT
- Stock Information
- Founded
- OSCR 2012
- IMVT 2018
- Country
- OSCR United States
- IMVT United States
- Employees
- OSCR N/A
- IMVT N/A
- Industry
- OSCR Accident &Health Insurance
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OSCR Finance
- IMVT Health Care
- Exchange
- OSCR Nasdaq
- IMVT Nasdaq
- Market Cap
- OSCR 3.2B
- IMVT 2.7B
- IPO Year
- OSCR 2021
- IMVT N/A
- Fundamental
- Price
- OSCR $14.39
- IMVT $18.12
- Analyst Decision
- OSCR Sell
- IMVT Buy
- Analyst Count
- OSCR 6
- IMVT 10
- Target Price
- OSCR $15.58
- IMVT $40.14
- AVG Volume (30 Days)
- OSCR 31.8M
- IMVT 1.3M
- Earning Date
- OSCR 08-06-2025
- IMVT 08-05-2025
- Dividend Yield
- OSCR N/A
- IMVT N/A
- EPS Growth
- OSCR N/A
- IMVT N/A
- EPS
- OSCR 0.46
- IMVT N/A
- Revenue
- OSCR $10,081,522,000.00
- IMVT N/A
- Revenue This Year
- OSCR $25.81
- IMVT N/A
- Revenue Next Year
- OSCR $0.60
- IMVT N/A
- P/E Ratio
- OSCR $31.14
- IMVT N/A
- Revenue Growth
- OSCR 54.26
- IMVT N/A
- 52 Week Low
- OSCR $11.20
- IMVT $12.72
- 52 Week High
- OSCR $23.79
- IMVT $34.47
- Technical
- Relative Strength Index (RSI)
- OSCR 38.73
- IMVT 68.50
- Support Level
- OSCR $15.95
- IMVT $16.88
- Resistance Level
- OSCR $17.46
- IMVT $17.10
- Average True Range (ATR)
- OSCR 1.36
- IMVT 0.71
- MACD
- OSCR -0.63
- IMVT 0.16
- Stochastic Oscillator
- OSCR 0.06
- IMVT 99.65
About OSCR Oscar Health Inc.
Oscar Health Inc is a health insurance company. The company provides various insurance plans for individuals, families, and employees. Also, the company provides virtual care, doctor support, scheduling appointments, and other related services. The company provides plans in the Medicare Advantage program to adults who are age 65 and older and eligible for traditional Medicare but who instead select coverage through a private market plan.
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.